ArticleNAR cancer2021
Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target.
Benjamin M Greulich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it